CCN1 and central nervous system cancer: Therefore, since our previous study indicated that CCN1 is required for mesenchymal migration, we hypothesise that glioma cells can overcome the anti-migratory drug treatment by inducing a mesenchymal–amoeboid transition (MAT) for continued migration and invasion.